<code id='ED21040C85'></code><style id='ED21040C85'></style>
    • <acronym id='ED21040C85'></acronym>
      <center id='ED21040C85'><center id='ED21040C85'><tfoot id='ED21040C85'></tfoot></center><abbr id='ED21040C85'><dir id='ED21040C85'><tfoot id='ED21040C85'></tfoot><noframes id='ED21040C85'>

    • <optgroup id='ED21040C85'><strike id='ED21040C85'><sup id='ED21040C85'></sup></strike><code id='ED21040C85'></code></optgroup>
        1. <b id='ED21040C85'><label id='ED21040C85'><select id='ED21040C85'><dt id='ED21040C85'><span id='ED21040C85'></span></dt></select></label></b><u id='ED21040C85'></u>
          <i id='ED21040C85'><strike id='ED21040C85'><tt id='ED21040C85'><pre id='ED21040C85'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:6318
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Eli Lilly’s Zepbound improved liver scarring in mid
          Eli Lilly’s Zepbound improved liver scarring in mid

          Illustration:STAT;Source:EliLilly/APEliLilly’sblockbusterdiabetesandobesitydrugimprovedlivingscarrin

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          Illumina board agrees to spin off Grail, as divestment plans proceed

          GrailIlluminasaidMondayafternoonthatitsboardofdirectorshadapprovedaspin-offofitscancertestsubsidiary